EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia

Marta Delsoglio, Rebecca Capener, Anita MacDonald, Anne Daly iD, Catherine Ashmore, Sarah Donald, Lisa Gaff, Louise VanDorp, Rachel Skeath, Charlotte Ellerton, Camille Newby, Georgina Dunning und 6 weitere

Nutrients · 2023

DOI: 10.3390/nu15163598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Marta Delsoglio und 17 weiteren Autor:innen. Beteiligte Einrichtung: Research and Innovation, Nutricia Ltd., White Horse Business Park, Trowbridge BA14 0XQ, UK. Hauptthemen laut MEDLINE: Phenylketonurias, Tyrosinemias. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nutricia (United Kingdom), Nutricia Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Poor palatability, large volume, and lack of variety of some liquid and powdered protein substitutes (PSs) for patients with phenylketonuria (PKU) and tyrosinemia (TYR) can result in poor adherence. This study aimed to evaluate a new unflavoured, powdered GMP-based PS designed to be mixed into drinks, foods, or with other PSs, in patients with PKU and TYR. (2)

Methods

Paediatric and adult community-based patients were recruited from eight metabolic centres and prescribed ≥1 sachet/day (10 g protein equivalent (PE)) of the Mix-In-style PS over 28 days. Adherence, palatability, GI tolerance, and metabolic control were recorded at baseline and follow-up. Patients who completed at least 7 days of intervention were included in the final analysis. (3)

Results

Eighteen patients (3–45 years, nine males) with PKU (n = 12) and TYR (n = 6) used the Mix-In-style PS for ≥7 days (mean 26.4 days (SD 4.6), range 11–28 days) alongside their previous PS, with a mean intake of 16.7 g (SD 7.7) PE/day. Adherence was 86% (SD 25), and GI tolerance was stable, with n = 14 experiencing no/no new symptoms and n = 3 showing improved symptoms compared to baseline. Overall palatability was rated satisfactory by 78% of patients, who successfully used the Mix-In-style PS in various foods and drinks, including smoothies, squash, and milk alternatives, as a top-up to meet their protein needs. There was no concern regarding safety/metabolic control during the intervention. (4)

Conclusions

The ‘Mix-In’-style PS was well adhered to, accepted, and tolerated. Collectively, these data show that providing a flexible, convenient, and novel format of PS can help with adherence and meet patients’ protein needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasTyrosinemiasGlycoproteinsGlycopeptidesHumansMaleFemaleChild, PreschoolChildAdolescentYoung AdultAdultMiddle AgedTreatment OutcomeGastrointestinal TractFoodBeverages

Stichwörter der Autor:innen

PKUTYRglycomacropeptidephenylketonuriaprotein substitutetyrosinemia

Substanzen

GlycoproteinsGlycopeptides

Autor:innen und Institutionen

  • Research and Innovation, Nutricia Ltd., White Horse Business Park, Trowbridge BA14 0XQ, UK.
  • Dietetic Department, Birmingham Children's Hospital, Birmingham B4 6NH, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.
  • Bristol University Hospitals NHS Foundation Trust, Bristol BS1 3NU, UK.

ORCID-Profile: Anne Daly, Rebecca J Stratton

Förderung

  • Nutricia (United Kingdom)
  • Nutricia Ltd.

Zitieren

APA

Delsoglio, M., Capener, R., MacDonald, A., Daly, A., Ashmore, C., Donald, S., Gaff, L., VanDorp, L., Skeath, R., Ellerton, C., Newby, C., Dunning, G., Dale, C., Hunjan, I., White, L., Allen, H., Hubbard, G. P., & Stratton, R. J. (2023). Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia. Nutrients. https://doi.org/10.3390/nu15163598

Vancouver

Delsoglio M, Capener R, MacDonald A, Daly A, Ashmore C, Donald S, et al. Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia. Nutrients. 2023. doi:10.3390/nu15163598

BibTeX
@article{Delsoglio2023,
  author = {Delsoglio, Marta and Capener, Rebecca and MacDonald, Anita and Daly, Anne and Ashmore, Catherine and Donald, Sarah and Gaff, Lisa and VanDorp, Louise and Skeath, Rachel and Ellerton, Charlotte and Newby, Camille and Dunning, Georgina and Dale, Clare and Hunjan, Inderdip and White, Lucy and Allen, Heather and Hubbard, Gary P and Stratton, Rebecca J},
  title = {Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15163598}
}
Kostenlos starten →